691889-35-7

Basic information

• Product Name: Carbamic acid, [(1R)-2-hydroxy-1-(4-hydroxyphenyl)ethyl]-, 1,1-dimethylethyl ester
• Synonyms: (R)-tert-butyl 2-hydroxy-1-(4-hydroxyphenyl)ethylcarbamate;[(R)-2-hydroxy-1-(4-hydroxy-phenyl)ethyl]carbamic acid tert-butyl ester;[(R)-2-hydroxy-1-(4-hydroxy-phenyl)-ethyl]-carbamic acid tert-butyl ester;(R)-tert-butyl (2-hydroxy-1-(4-hydroxyphenyl)ethyl)carbamate;(R)-N-boc-4-hydroxyphenylglycinol
• CAS NO: 691889-35-7
• Molecular Formula: C13H19NO4
• Molecular Weight: 253.298
• Mol File: 691889-35-7.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [(1R)-2-hydroxy-1-(4-hydroxyphenyl)ethyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(1R)-2-hydroxy-1-(4-hydroxyphenyl)ethyl]-, 1,1-dimethylethyl ester(691889-35-7)
• EPA Substance Registry System: Carbamic acid, [(1R)-2-hydroxy-1-(4-hydroxyphenyl)ethyl]-, 1,1-dimethylethyl ester(691889-35-7)

Safety Data

• Hazardous Substances Data: 691889-35-7(Hazardous Substances Data)

Upstream product

• 4248-19-5 tert-butyl carbazate 
• 199393-31-2 (R)-2-(tert-butoxycarbonyl)amino-2-(4-benzyloxyphenyl)ethanol 
• 4397-53-9 p-benzyloxybenzaldehyde 
• 36438-64-9 p-benzyloxystyrene 
• 27460-85-1 N-(tert-butoxycarbonyl)-D-(4-hydroxyphenyl)glycine 
• 37763-23-8 D-2-p-hydroxyphenylglycine methyl ester 
• 22818-40-2 D-4-hydroxyphenylglycine 
• 57591-61-4 methyl (R)-2-amino-2-(4-hydroxyphenyl)acetate hydrochloride 
• 586413-61-8 (R)-N-(t-butoxycarbonyl)-4-(t-butyldimethylsiloxy)phenylglycine methyl ester 
• 143323-49-3 (R)-methyl 2-((tert-butoxycarbonyl)amino)-2-(4-hydroxyphenyl)acetate 

Downstream Products

• 1391355-45-5 (R)-4-hydroxyphenylglycinol hydrochloride 
• 1286280-51-0 {(R)-2-hydroxy-1-[4-((S)-2-methyl-butoxy)phenyl]ethyl}carbamic acid t-butyl ester 
• 1286280-78-1 tert-butyl (R)-2-(1,3-dioxo-1,3-dihydroisoindol-2-yl)-1-(4-((S)-2-methylbutoxy)phenyl)ethylcarbamate 
• 1286280-73-6 (2R)-2-amino-2-[4-(2-methylpentyloxy)phenyl]ethanol hydrochloride 
• 1286280-79-2 (1S,2S)-2-thiophen-2-yl-cyclopropanecarboxylic acid {(R)-2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-1-[4-((S)-2-methyl-butoxy)phenyl]ethyl}amide 
• 1286280-41-8 (1S,2S)-2-thiophen-2-yl-cyclopropanecarboxylic acid {(R)-2-hydroxy-1-[4-(2-methyl-pentyloxy)phenyl]ethyl}amide 
• 1286280-43-0 (1S,2S)-2-thiophen-2-yl-cyclopropanecarboxylic acid {(R)-2-amino-1-[4-((S)-2-methyl-butoxy)phenyl]ethyl}amide 
• 1286280-52-1 {(R)-2-hydroxy-1-[4-((S)-2-methyl-butoxy)phenyl]ethyl}amine hydrochloride 
• 1286280-32-7 (1S,2S)-thiophen-2-yl-cyclopropanecarboxylic acid {(R)-2-hydroxy-1-[4-((S)-2-methyl-butoxy)phenyl]ethyl}amide 
• 1286280-72-5 tert-butyl (1R)-2-hydroxy-1-[4-(2-methylpentyloxy)phenyl]ethylcarbamate 
• 143674-61-7 (4R)-N-(tert-butoxycarbonyl)-2,2'-dimethyl-4-[4-hydroxyphenyl]-1,3-oxazoline 
• 1454273-76-7 (R)-ethyl 2-(4-(1-((tert-butoxycarbonyl)amino)-2-hydroxyethyl)phenoxy) acetate 
• 1454273-22-3 (R)-2-(4-(1-amino-2-(1-(2-fluoro-6-(trifluoromethyl)benzyl)-2,4-dioxo-1'-((5-(trifluoromethyl)furan-2-yl)methyl)-1H-spiro[furo[3,4-d]pyrimidine-5,4'-piperidin]-3(2H,4H,7H)-yl)ethyl)phenoxy)acetic acid 
• 1454273-79-0 (R)-ethyl 2-(4-(1-amino-2-(1-(2-fluoro-6-(trifluoromethyl)benzyl)-2,4-dioxo-1'-((5-(trifluoromethyl)furan-2-yl)methyl)-1H-spiro[furo[3,4-d]pyrimidine-5,4'-piperidin]-3(2H,4H,7H)-yl)ethyl)phenoxy)acetate 

Relevant articles and documents

Bcl-2 INHIBITORS

Disclosed herein is a compound of Formula (I) for inhibiting Bcl-2 and treating disease associated with undesirable bcl-2 activity (Bcl-2 related diseases), a method of using the compounds disclosed herein for treating dysregulated apoptotic diseases incl

GONADOTROPIN RELEASING HORMONE RECEPTOR ANTAGONISTS, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

The present invention provides gonadotropin releasing hormone receptor antagonists and the pharmaceutical composition comprising the same, which can be useful in preventing or treating a sex hormone-related disease such as endometriosis, amenorrhea, irregular menstruation, uterine myoma, uterine fibroids, polycystic ovarian disease, lupus erythematous, hypertrichosis, precocious puberty, short stature, acne, alopecia, gonadal steroid-dependent neoplasms, gonadotropin-producing pituitary adenoma, sleep apnea, irritable bowel syndrome, premenstrual syndrome, benign prostatic hyperplasia, contraception, and infertility, as well as Alzheimer disease

BIPHENYL DERIVATIVES AS MODULATORS OF THE HISTAMINE-H3 RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

Biphenyl derivatives of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the H3 histamine receptor. (Ia) Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of histamine H3-associated disorders, such as cognitive disorders, epilepsy, brain trauma, depression, obesity, disorders of sleep and wakefulness, such as narcolepsy, shift-work syndrome, drowsiness as a side effect from a medication, maintenance of vigilance to aid in completion of tasks and the like, cataplexy, hypersomnia, somnolence syndrome, jet lag, sleep apnea and the like, attention deficit hyperactivity disorder (ADHD), schizophrenia, allergies, allergic responses in the upper airway, allergic rhinitis, nasal congestion, dementia, Alzheimer's disease, pain and the like.